
Isoray ISR
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
73.8 M |
Marktkapitalisierung |
$ 108 M |
EBITDA (LTM) |
$ -41.2 M |
P/E (LTM) |
- |
P/S (LTM) |
13.42 |
EPS (LTM) |
-1.03 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Repro Med Systems
KRMD
|
$ 4.38 | -1.13 % | $ 202 M | Nasdaq Capital Market | ||
|
ICU Medical
ICUI
|
$ 130.03 | 0.07 % | $ 3.2 B | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 109.14 | 1.19 % | $ 2.47 B | Nasdaq Global Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 178.63 | 0.11 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 67.82 | -0.46 % | $ 4.01 B | Nasdaq Global Select Market,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.25 | 1.67 % | $ 4.41 B | NYSE | ||
|
OraSure Technologies
OSUR
|
$ 3.05 | -0.97 % | $ 224 M | Nasdaq Global Select Market,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.85 | 2.36 % | $ 26.3 M | Nasdaq Capital Market | ||
|
Pro-Dex
PDEX
|
$ 49.96 | 4.2 % | $ 164 M | Nasdaq Global Select Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Pulse Biosciences
PLSE
|
$ 20.99 | 0.29 % | $ 1.41 B | Nasdaq Global Select Market | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Repligen Corporation
RGEN
|
$ 117.31 | 0.82 % | $ 6.54 M | Nasdaq Global Select Market,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Nephros
NEPH
|
$ 3.05 | -1.93 % | $ 31.7 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 57.71 | -1.28 % | $ 2.9 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 16.59 | -0.12 % | $ 8.51 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 222.85 | 0.84 % | $ 22 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 106.29 | 0.3 % | $ 4.74 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.57 | -1.31 % | $ 432 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 472.25 | -1.21 % | $ 169 B | Nasdaq Global Select Market,SPB | ||
|
AtriCure
ATRC
|
$ 29.51 | -0.91 % | $ 1.41 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.61 | 0.1 % | $ 198 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 118.9 | 0.64 % | $ 3.81 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 19.51 | 1.77 % | $ 899 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | -0.35 % | $ 23.1 M | NYSE American | ||
|
Utah Medical Products
UTMD
|
$ 64.65 | -0.74 % | $ 235 M | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 6.04 | -1.51 % | $ 51.2 K | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 70.56 | 0.45 % | $ 14 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 106.44 | -0.37 % | $ 5.16 B | NYSE,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.21 | -2.43 % | $ 231 M | Nasdaq Global Market | ||
|
ResMed
RMD
|
$ 228.86 | 0.39 % | $ 33.4 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.52 | -0.2 % | $ 25.7 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.69 | -4.58 % | $ 20.7 M | NYSE American | ||
|
West Pharmaceutical Services
WST
|
$ 243.83 | 0.92 % | $ 17.6 B | NYSE,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.67 | 1.08 % | $ 2.33 B | Nasdaq Global Select Market,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 18.93 | 2.3 % | $ 938 M | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.79 | -2.72 % | $ 163 M | NYSE American | ||
|
Becton, Dickinson and Company
BDX
|
$ 156.78 | 0.35 % | $ 45.1 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 74.3 | 0.22 % | $ 40.4 B | NYSE |